Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Centrally acting antihypertensive agents.

G Leonetti1

  • 1Istituto di Clinica Medica Generale e Terapia Medica, Università di Milano, Italy.

Journal of Cardiovascular Pharmacology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to "Sudden death after facial impacts: Is the brainstem involved?" [Morphologie 106 (2022) 217-223].

Morphologie : bulletin de l'Association des anatomistes·2024
Same author

Hyperbilirubinemia and Gilbert's syndrome in Cystic Fibrosis patients treated with elexacaftor/tezacaftor/ivacaftor.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2023
Same author

Sudden death after facial impacts: Is the brainstem involved?

Morphologie : bulletin de l'Association des anatomistes·2021
Same author

Combined use of postmortem 3D computed tomography reconstructions and 3D-design software for postmortem ballistic analysis.

Diagnostic and interventional imaging·2017
Same author

Forensic use of the Greulich and Pyle atlas: prediction intervals and relevance.

European radiology·2016
Same author

[Responsibility for prescribing and monitoring an act transfusion and safety blood transfusion].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2014
Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
See all related articles

Centrally acting antihypertensive drugs like alpha-methyldopa and clonidine appear to lower blood pressure similarly across age groups. However, their effectiveness is more strongly linked to pretreatment blood pressure levels.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Geriatrics

Background:

  • Age significantly influences plasma catecholamine levels, baroreflex activity, and hemodynamic patterns.
  • Sympathetic nervous system-acting drugs might be expected to have age-dependent effects on blood pressure.
  • Limited data exist on the comparative antihypertensive efficacy of centrally acting drugs across different age demographics.

Purpose of the Study:

  • To evaluate the antihypertensive efficacy of alpha-methyldopa and clonidine in relation to patient age.
  • To investigate the correlation between blood pressure reduction and pretreatment blood pressure values.
  • To assess the risk-benefit profile of centrally acting antihypertensives in diverse age populations.

Main Methods:

  • Review of published works reporting the effects of alpha-methyldopa and clonidine on blood pressure.

Related Experiment Videos

  • Analysis of available data concerning patient age and blood pressure response.
  • Correlation analysis between blood pressure reduction and pretreatment blood pressure.

    • Main Results:

    • Available data suggest alpha-methyldopa and clonidine lower blood pressure similarly in young, middle-aged, and elderly patients.
    • Blood pressure reduction is significantly correlated with pretreatment blood pressure values for both drugs.
    • Age data in most studies are reported as mean or range, hindering precise age-specific comparisons.

    Conclusions:

    • The antihypertensive efficacy of alpha-methyldopa and clonidine does not appear to be significantly age-dependent.
    • Pretreatment blood pressure is a key determinant of blood pressure reduction achieved with these agents.
    • The risk-benefit assessment of centrally acting antihypertensives across different age groups requires further investigation.